To validate the results obtained from miRNA-mRNA analysis in breast cancer cells, we selected the NF-κB pathway, as it is known to be overexpressed in breast tumour samples (73) and TNBC has high NF-κB compared to ER+ve cancers (74). The gene discussed is NFKB1; the disease is breast carcinoma.